Apart from the AP1189 granulate, the placebo tablet and AP1189 tablet are identical., AP1189 Tablet
SynAct-CS003
Phase 2 small_molecule active
Quick answer
Apart from the AP1189 granulate, the placebo tablet and AP1189 tablet are identical., AP1189 Tablet for Idiopathic membranous nephropathy and severe proteinuria is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Idiopathic membranous nephropathy and severe proteinuria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active